Department of Pharmacology, The Johns Hopkins School of Medicine, 725 N. Wolfe Street, Baltimore, MD 21205, USA.
J Neurosci Res. 2009 Nov 15;87(15):3267-76. doi: 10.1002/jnr.21992.
Myelin-associated glycoprotein (MAG) is expressed on the innermost myelin membrane wrap, directly apposed to the axon surface. Although it is not required for myelination, MAG enhances long-term axon-myelin stability, helps to structure nodes of Ranvier, and regulates the axon cytoskeleton. In addition to its role in axon-myelin stabilization, MAG inhibits axon regeneration after injury; MAG and a discrete set of other molecules on residual myelin membranes at injury sites actively signal axons to halt elongation. Both the stabilizing and the axon outgrowth inhibitory effects of MAG are mediated by complementary MAG receptors on the axon surface. Two MAG receptor families have been described, sialoglycans (specifically gangliosides GD1a and GT1b) and Nogo receptors (NgRs). Controversies remain about which receptor(s) mediates which of MAG's biological effects. Here we review the findings and challenges in associating MAG's biological effects with specific receptors.
髓鞘相关糖蛋白(MAG)表达在内髓鞘膜的最内层,与轴突表面直接相对。尽管 MAG 不是髓鞘形成所必需的,但它能增强轴突-髓鞘的长期稳定性,有助于形成郎飞结,并调节轴突细胞骨架。除了在轴突-髓鞘稳定中的作用外,MAG 还能抑制损伤后的轴突再生;MAG 以及损伤部位残留髓鞘膜上的一组离散分子会主动向轴突发出信号,使其停止延伸。MAG 的稳定和轴突生长抑制作用都是通过轴突表面互补的 MAG 受体来介导的。已经描述了两种 MAG 受体家族,唾液酸糖蛋白(特别是神经节苷脂 GD1a 和 GT1b)和 Nogo 受体(NgR)。关于哪种受体(s)介导 MAG 的哪种生物学效应,仍存在争议。在这里,我们回顾了将 MAG 的生物学效应与特定受体相关联的发现和挑战。